Real-world evaluation of compliance and preference in XXXX treatment.

@entity1 @entity3393 @entity11544 @entity195
PURPOSE: @entity11544 transdermal patch has shown higher caregiver satisfaction and greater preference than oral formulation in @entity1 with @entity195 . However, there is limited literature available related to caregiver preference or treatment compliance in real-world clinical settings. To date, no such data are available from Asia and the Middle East, which account for a sizeable proportion of @entity1 with @entity195 . The objective of this study was to evaluate treatment preference and compliance with oral and transdermal medications in daily clinical practice in an ethnically diverse @entity1 population from Asia and the Middle East with mild-to-moderate @entity195 . @entity1 AND METHODS: RECAP (Real-world Evaluation of Compliance And Preference in the treatment of @entity195 ) was a 24-week, multicenter, prospective, noninterventional study. Two treatment cohorts were observed during the study: oral (cholinesterase inhibitors or @entity3393 ) and transdermal ( @entity11544 patch). Caregiver preference, physician preference, and @entity1 compliance were evaluated at week 24. RESULTS: A total of 978 of 1,931 enrolled @entity1 (mean age: 72.8 years; 50.5% female) were in the transdermal cohort. For @entity1 with exposure to both oral and transdermal monotherapy (n=330), a significant caregivers' preference for the transdermal monotherapy was observed (82.7%; P<0.0001). Of the 89 participating physicians, 71 indicated preference for transdermal monotherapy. @entity1 compliance was also significantly higher for transdermal than oral monotherapy (P<0.0001). CONCLUSION: Our study showed higher caregiver and physician preference and greater @entity1 compliance with transdermal monotherapy in daily practice.
